Expert Roundtable: Racial Disparities in Dermatology Care
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
Prurigo Nodularis
Skin of Color Disproportionately Affected by Cutaneous Disorders
The racial and ethnic distribution of common dermatologic disorders seen at a US tertiary care center are characterized.
Intranasal Butorphanol Effectively Reduces Pruritus
One of the largest case series of intranasal butorphanol rescue therapy in treating intractable itch demonstrates success.
Prurigo Nodularis, Lichen Simplex Chronicus Linked to Range of Mental Health Disorders
In a multivariable logistic regression, PN and LSC were associated with having 1 or more mental health disorders.
Serlopitant Not Statistically Significantly Better Than Placebo in Prurigo Nodularis Studies
Menlo Therapeutics announced topline results from two phase 3 studies of serlopitant for the treatment of pruritus associated with prurigo nodularis.
Nemolizumab Reduces Pruritis in Moderate to Severe Prurigo Nodularis
Nemolizumab was associated with a greater reduction in pruritus and severity of skin lesions compared with placebo in patients with prurigo nodularis.
Off-Label Prescribing in Dermatology
The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the most commonly employed treatments, the ethical implications of off-label use, and the need for patient education.
Nemolizumab Gets Breakthrough Therapy Status for Prurigo Nodularis
Nemolizumab is a first-in-class humanized monoclonal antibody that blocks the signaling of IL-31 by targeting IL-31 receptor alpha.
Race Linked to Increased Risk for Pruritic Skin Conditions in People With HIV
Black patients with HIV may be at increased risk for pruritic disorders compared with race-matched controls and white patients with HIV.
Review Highlights Lack of Tx Options for Prurigo Nodularis
A new review provides evidence-based guidance for practitioners treating the dermatologic condition prurigo nodularis and highlights gaps in treatment development and research.
-
Loading...
-
Loading...
Next post in General Dermatology
